Enregistrement :
8
de
11
(2022-11-01
à
2023-04-28)
Subvention, Contribution ou autre avantage financier
Seeking funding to allow for increased research and development and other expenditures into two clinical-stage antibodies to treat acute respiratory distress syndrome (the primary cause of death from COVID-19) from the Industrial Research Assistance Program and the Strategic Innovation Fund.